Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy

  • Technology appraisal guidance
  • TA307
  • Published: 

Colorectal cancer (metastatic) - aflibercept: final appraisal determination

Please note that these documents contain information that was designated academic in confidence by the manufacturer at the time when the Final Appraisal Determination was released but has been made publicly available for guidance publication. This information is highlighted.

This page was last updated: 21 August 2014